AstraZeneca's woes continue
AstraZeneca has admitted it faces another difficult year of falling sales in 2013 after patent expiries last year meant revenues slumped 17 per cent to £27.9bn.
Pascal Soriot, the new chief executive of Britain's second-biggest drug maker, was parachuted in from rival Roche last year after David Brennan quit under pressure from disappointed shareholders. Mr Soriot warned that revenues will face a "mid-to-high single-digit percentage decline" this year. That follows pre-tax profits for 2012 coming in 38 per cent lower than the previous year, at £7.7bn.
The news was even worse than City analysts had expected, and the shares fell 99.5p to 3,053p.
Astra's revenue stream is drying up as some of its key drugs are having to compete against cheaper generic rivals. The blockbusters Nexium and Crestor lose the crucial United States patent protection in 2014 and 2016.
- 1 The difference between a migrant and refugee, in one sentence
- 2 Miley Cyrus calls out hypocrisy of women’s nipples being taboo
- 3 iPhone 5c to be discontinued, no iPhone 6c to replace it
- 4 Jozef Wesołowski: Former Catholic archbishop found dead ahead of child sexual abuse trial
- 5 Blood Moon and Supermoon: September to bring brightest – and dimmest – full Moon of the year on same night
Spain accused of 'provocation' after letting Russian submarine refuel off Gibraltar
Allonautilus scrobiculatus: World's 'rarest' creature spotted for only the third time ever
Miley Cyrus address Robin Thicke VMA controversy: ‘He wanted me as naked as possible, but I got the heat because I’m a woman’
Miley Cyrus calls out hypocrisy of women’s nipples being taboo
Celebrity Big Brother 2015: Tila Tequila kicked off show after 'describing Hitler as a good man'
Climate change: 2015 will be the hottest year on record 'by a mile', experts say
Labour leadership: Jeremy Corbyn accused of 'deluding' young supporters with 'claptrap'
'Women only' train carriages: Jeremy Corbyn unveils radical move to tackle public harassment
Black holes are a passage to another universe, says Stephen Hawking
Iain Duncan Smith 'should resign over disability benefit death figures', says Jeremy Corbyn
Iain Duncan Smith calls for urgent ESA overhaul as part of drive to cut down welfare costs
iJobs Money & Business
£25000 - £30000 per annum: Recruitment Genius: From modest beginnings the comp...
£35000 - £40000 per annum: Recruitment Genius: From modest beginnings the comp...
£15000 - £65000 per annum: Recruitment Genius: This is an exciting opportunity...
£18000 - £20000 per annum: Recruitment Genius: This is a fantastic opportunity...